Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Prinses Máxima Centrum Voorpagina
Nederlands
English
Voorpagina
Profielen
Onderzoeksgroepen
Uitrusting
Onderzoeksoutput
Prijzen
Activiteiten
Knipsels
Zoeken op expertise, naam of affiliatie
Survival and Health Care Burden of Children with Retinoblastoma in Europe
Gianni Virgili
, Riccardo Capocaccia
, Laura Botta
, Damien Bennett
, Theodora Hadjistilianou
, Kaire Innos
,
Henrike Karim-Kos
, Claudia E. Kuehni
, Ursula Kuhnel
, Cinzia Mazzini
, Adela Canete Nieto
, Keiu Paapsi
, Mariacristina Parravano
, Cécile M. Ronckers
, Silvia Rossi
, Charles Stiller
, Giulio Vicini
, Otto Visser
, Gemma Gatta
Group Karim-Kos
Onderzoeksoutput
:
Bijdrage aan tijdschrift
›
Artikel
›
peer review
3
Citaten (Scopus)
Overzicht
Vingerafdruk
Vingerafdruk
Duik in de onderzoeksthema's van 'Survival and Health Care Burden of Children with Retinoblastoma in Europe'. Samen vormen ze een unieke vingerafdruk.
Sorteer per
Gewicht
Alfabetische volgorde
Keyphrases
Europe
100%
Retinoblastoma
100%
Caregiver Burden
100%
Standardized Incidence Ratio
40%
European children
30%
Cancer Registry
20%
5-year Survival
20%
Subsequent Malignant Neoplasms
20%
Epidemiology
10%
Oncology
10%
Survival Rate
10%
Incidence Rate
10%
Soft Tissue Sarcoma
10%
International Classification of Diseases
10%
Hematological Cancer
10%
European Countries
10%
Second Tumors
10%
Stage at Diagnosis
10%
Malignant Behavior
10%
Annual Incidence
10%
EUROCARE
10%
Bone Tissue
10%
Third Edition
10%
Second Primary Tumor
10%
Time Trends
10%
Population Data
10%
Trend Analysis
10%
ICD-O
10%
Fifth Digit
10%
Registry Study
10%
Time Coverage
10%
Estonia
10%
Bulgaria
10%
Medicine and Dentistry
Retinoblastoma
100%
Health Care
100%
Standardized Incidence Ratio
40%
Malignant Neoplasm
20%
Cancer Registry
20%
Tumor
20%
ICD-O-3
20%
Second Cancer
10%
Cohort Analysis
10%
Cohort Effect
10%
Soft Tissue Sarcoma
10%
Bone Tissue
10%
Small Finger
10%
Nursing and Health Professions
Retinoblastoma
100%
Health Care
100%
Standardized Incidence Ratio
40%
Malignant Neoplasm
20%
Cancer Registry
20%
ICD-O-3
20%
Cohort Analysis
10%
Soft Tissue Sarcoma
10%
Second Cancer
10%
Pharmacology, Toxicology and Pharmaceutical Science
Retinoblastoma
100%
Standardized Incidence Ratio
40%
Malignant Neoplasm
20%
Cancer Registry
20%
ICD-O-3
20%
Cohort Study
10%
Soft Tissue Sarcoma
10%
Second Cancer
10%
Agricultural and Biological Sciences
Malignant Neoplasm
100%